[Rivaroxaban: a decisive step forward in the management of postoperative thromboembolic disease?].
Mantz
J
J
D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000188:drug therapy* / Q000517:prevention & control; D000069552:Rivaroxaban; D013876:Thiophenes / Q000627:therapeutic use*; D013923:Thromboembolism / Q000188:drug therapy* / Q000517:prevention & control
D005343:Fibrinolytic Agents; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban